By Kevin Madagan
Ampersand Capital Partners has announced its acquisition of Nektar Therapeutics’ PEGylation reagent manufacturing business.
The business, which will be branded Gannet BioChem and continue to operate out of its facility in Huntsville, Alabama, develops, scales and manufactures
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand Acquires Nektar Therapeutics’ PEGylation